Radionuclide imaging of the parathyroid glands: Patterns, pearls, and pitfalls

Radiographics

Volumn 24, Issue 4, 2004, Pages 1101-1115

  Smith, Joel R ^a   Oates, M Elizabeth ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Parathyroid, hyperparathyroidism, 274.531; Parathyroid, neoplasms, 274.363; Parathyroid, radionuclide studies, 274.12175; Parathyroid, SPECT, 274.12162

Indexed keywords

CALCIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; TECHNETIUM 99M; TETROFOSMIN TC 99M; VITAMIN D;

BIOCHEMISTRY; CALCIUM BLOOD LEVEL; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DRUG HALF LIFE; HUMAN; OSTEOLYSIS; PARATHYROID ADENOMA; PARATHYROID DISEASE; PARATHYROID GLAND; RADIATION DOSE; RADIOLOGIST; REVIEW; SCINTIGRAPHY; THYROID GLAND; URINARY EXCRETION;

EID: 3242707017     PISSN: 02715333     EISSN: None     Source Type: Journal    
DOI: 10.1148/rg.244035718     Document Type: Review

References (12)

1. Civelek AC, Ozalp E, Donovan P, Udelsman R. Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery 2002; 131:149-157.
2. 99mTc sestamibi scanning and intraoperative quick parathormone assay. Surgery 1997; 122:1107-1110.
3. Wilkinson RH Jr, Leight GS Jr, Garner SC, Borges-Neto S. Complementary nature of radio-tracer parathyroid imaging and intraoperative parathyroid hormone assays in the surgical management of primary hyperparathyroid disease: case report and review. Clin Nucl Med 2000; 25:173-178.
4. 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 2003; 44:904-908.
5. Ishibashi M, Nishida H, Hiromatsu Y, Kojima K, Tabuchi E, Hayabuchi N. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med 1998; 39:320-324.
6. Fjeld JG, Erichsen K, Pfeffer PF, Clausen OP, Rootwelt K. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi. J Nucl Med 1997; 38:831-834.
7. Billotey C, Sarfati E, Aurengo A, et al. Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy. J Nucl Med 1996; 37:1773-1778.
8. Taillefer R, Boucher Y, Potvin C, Lamert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992; 33:1801-1807.
9. Bilezikian JP, Marcus R, Levine MA. The parathyroids: basic and clinical concepts. New York, NY: Raven, 1994.
10. Chen CC, Skarulis MC, Fraker DL, Alexander R, Marx SJ, Spiegel AM. Technetium-99m-sestamibi imaging before reoperation for primary hyperparathyroidism. J Nucl Med 1995; 36:2186-2191.
11. Perez-Monte JE, Brown ML, Shah AN, Ranger NT, Watson CG, Carty SE. Parathyroid adenomas: accurate detection and localization with Tc-99m sestamibi SPECT. Radiology 1996; 201:85-91.
12. Lee VS, Spritzer CE, Coleman RE, Wilkinson RH, Coogan AC, Leight GS. The complementary roles of fast spin echo MR imaging and double-phase 99m Tc-sestamibi scintigraphy for localization of hyperfunctioning parathyroid glands. AJR Am J Roentgenol 1996; 167:1555-1562.